Epidemiology

Hepatocellular Carcinoma

Volumn , Issue , 2008, Pages 1-23

  Leong, Trishe Y M ^a   Leong, Anthony S Y ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988565728     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770059_0001     Document Type: Chapter

References (88)

1. Leong AS-Y (1999). Epidemiology, risk factors, etiology, premalignant lesions and carcinogenesis. In: Leong AS-Y, Liew CT, Lau JWY, Johnson PJ (eds.), Hepatocellular Carcinoma. Contemporary Diagnosis, Investigation and Management, Arnold, London, England, pp. 1-29.
2. Rustgi VK (1987). Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 16:545-51.
3. Munoz N, Bosch X (1988). Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds.), Neoplasms of the Liver, Springer-Verlag, Berlin, Germany, pp. 3-19.
4. Simonetti RG, Camma C, Fiorello F, et al. (1991). Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36:962-72.
5. Okuda K, Kojiro M, Okuda H (1993). Neoplasms of the liver. In: Schiff L, Schiff ER (eds.), Diseases of the Liver, 7th ed., JB Lippincott Co., Philadelphia, PA, pp. 1236-96.
6. Yang BH, Xia JL, Huang LW, etal. (2003). Changes of clinical aspect of primary liver cancer in China during the past 30 years — control study of 3250 cases with primary liver cancer. Zhonghua YiXue ZaZhi 83:1053-7.
7. Petry W, Heintges T, Hensel F, et al. (1997). Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 35:1059-67.
8. Oon CJ, Rauff A, Tan LKA (1989). Treatment of primary liver cancer in Singapore. A review of 3200 cases seen between January 1, 1977 and July 31, 1987. Cancer Chemother Pharmacol 23(Suppl):813-6.
9. Wu PC (1983). Hepatocellular carcinoma: epidemiology and pathology. Hong KongPract 5:790-5.
10. Munozn, Linsell A (1982). Epidemiology of primary liver cancer. In: CorreaP, Haenzel W (eds.), Epidemiology of Cancer in the Digestive Tract, Nijhoff, The Hague, The Netherlands, pp. 161-95.
11. Lau JY-N, Lai C-L (1990). Hepatocarcinogenesis. Trop Gastroenterol 11:9-24.
12. Tong MJ, Hwang SJ (1994). Hepatitis B virus infection in Asian countries. Gastroenterol Clin North Am 23:523-36.
13. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:128.
14. Yu SZ (1995). Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 10:674-82.
15. Craig JR, Peters R, Edmondson H (1989). Tumors of the Liver and Intrahep-atic Bile Ducts, Fascicle 26. Armed Forces Institute of Pathology, Washington DC, WA.
16. Saracci R, Repetto F (1980). Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. J Natl Cancer Inst 65:241-6.
17. Cortes-Espinosa T, Mondragon-Sanchez R, Hurtado-Andrade H, Sanchez-Cisneros R (1997). Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review. Hepatogastroenterology 44:1401-3.
18. Fan ST, Wong J (1996). Hepatocellular carcinoma in the East. In: Terblanche J (ed.), Hepatobiliary Malignancy, Churchill Livingstone, London, England, pp. 169-83.
19. Newberne PM, Butler WD (1978). Rat Hepatic Neoplasia. MIT Press, Cambridge, MA.
20. Grasso P (1987). Experimental liver tumours in animals. In: Williams R, Johnson PJ (eds.), Liver Tumors. Bailliere’s Clinical Gastroenterology, Bailiere, London, England, pp. 185-305.
21. Nagasue N, Kohno H, Chang Y, et al. (1990). Specificity of androgen receptors of hepatocellular carcinoma and liver in humans. Hepatogastroenterology 37:474-9.
22. Eagon PK, Francavilla A, Di Leo A, et al. (1991). Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. DigDis Sci 36:1303-8.
23. Carr BI, van Thiel DH (1990). Hormonal manipulation of human hepatocellular carcinoma. J Hepatol 11:287-9.
24. D’Arville CN, Johnson PJ (1990). Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma— an overview. J Steroid Biochem Mol Biol 37:1007-12.
25. Tarao K, Ohkawa S, Shinmizu A, et al. (1993). The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 72:369-74.
26. See KL, See M, Glund C (1992). Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12:73-9.
27. Moore SW, Hesseling PB, Wessels G, Schneider JW (1997). Hepatocellular carcinoma in children. Pediatr SurgInt 12:266-70.
28. Bianchi L (1993). Glucogen storage disease I and hepatocellular carcinoma. Eur J Pediatr 152(Suppl 1):S63-70.
29. Weinberg AG, Finegold MJ (1983). Primary hepatic tumors in childhood. Hum Pathol 14:512-37.
30. Alberts SR, Lanier AP, McMahon BJ (1991). Clustering of hepatocellular carcinoma in Alaska native families. Genet Epidemiol 8:127-39.
31. Shen FM, Lee MK, Gong HM (1991). Complex segregation analysis ofprimary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am JHum Genet 49:88-93.
32. Leuschner I, Harms D, Schmidt D (1988). The association of hepatocellular carcinoma in childhood with hepatitis B virus infection. Cancer 62:2363-9.
33. Cheah PL, Looi L-M, Lim HP, Yap SF (1990). Childhood primary hepatocellular carcinoma and hepatitis B virus infection. Cancer 65:174-6.
34. Laferia G, Kaye SB, Crean GP (1988). Hepatocellular and gastric carcinoma associated with familial polyposis coli. JSurg Oncol 38:19-21.
35. Weinstein S, Scottalini AG, Loo ST (1985). Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med 109:1000-4.
36. McGoldrick JP, Boston VE, Glasgow JKT (1986). Hepatocellular carcinoma associated with congenital macronodular cirrhosis in a neonate. J Pediatr Surg 21:177-9.
37. Weinberg AG, Mize CE, Worthan HG (1976). The occurrence of hepatoma in the chronic form of hereditary tyrosinaemia. J Pediatr 88:434-8.
38. Dehner LP, Snover DC, Sharp HL, et al. (1989). Hereditary tyrosinaemia type I (chronic form). Hum Pathol 20:149-58.
39. Kauppinen R, Mustajoki P (1988). Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57:117-20.
40. Gangaidzo IT, GordeukVR(1995). Hepatocellular carcinoma and African iron overload. Gut 37:727-30.
41. Crystal RG (1990). Alpha-1-antitrypsin deficiency, emphysema and liver disease. J Clin Invest 85:1343-5.
42. Simpson IW (1982). Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 82:171-8.
43. Purtilo DT, Gottlieb LS (1973). Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968). Cancer 32:458-62.
44. Niederau C, Fischer R, Sonnenberg A, etal. (1985). Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hematochromatosis. N Engl J Med 313:1256-62.
45. Chu NS, Hung TP (1993). Geographic variations in Wilson’s disease. J Neurol Sci 117:1-7.
46. Shikata T (1987). Primary liver carcinoma and liver cirrhosis. In: Okuda K, Peters RL (eds.), Hepatocellular Carcinoma, John Wiley &Sons, New York, NY, pp. 53-68.
47. Yu MC, Yuan JM, Govindarajan S, Ross RK (2000). Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14:703-9.
48. Kaplan DE, Reddy KR (2003). Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clin Liver Dis 7:683-714.
49. El-Serag HB (2002). Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35:872-8.
50. Melnick JL (1983). Hepatitis B virus and liver cancer. In: Phillips LA (ed.), Viruses Associated with Human Cancer, Marcel Dekker, New York, NY, pp. 337-67.
51. Beasley RP, Hwang LY (1984). Epidemiology of hepatocellular carcinoma. In: Vyas GH, DienstagJL, Hoofnagle JH (eds.), Viral Hepatitis and Liver Disease, Grune &Stratton, New York, NY, pp. 209-24.
52. Blum HE, Offensperger WB, Walter E, etal. (1987). Hepatocellular carcinoma and hepatitis B virus infection: molecular evidence for monoclonal origin and expansion of malignantly transformed hepatocytes. J Cancer Res Clin Oncol 113:466-72.
53. Govindarajan S, Craig JR, Valinluck B (1988). Clonal origin of hepatitis B virus-associated hepatocellular carcinoma. Hum Pathol 19:403-5.
54. Goodgame B, Shaheen NJ, Galanko J, El-Serag HB (2003). The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol 98:2535-42.
55. Di Bisceglie AM, Lyra AC, Schwartz M, et al. (2003). Hepatitis C-related carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98: 2060-3.
56. Garcia-Torres ML, Zaragoza A, Giner R, et al. (2003). Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000. Rev Esp Enferm Dig 95:385-8, 381-4.
57. Fattovich G (1998). Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 3:1206-13.
58. Fujioka S, Shimomura H, Iwasaki Y, etal. (2003). Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients. Dig Dis Sci 48:1920-4.
59. Matthews G, Bhagani S (2003). The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. J HIV Ther 8:77-84.
60. Kondo F, Wada K, Nagato Y, etal. (1989). Biopsy diagnosis of well differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9: 751-5.
61. Su DL (1979). Drinking water and liver cancer: an epidemiological approach to the etiology of this disease in China. Chin Med J (Engl) 92:748-52.
62. Willett WC, MacMahon B (1984). Diet and cancer — an overview. N Engl J Med 310:633-8, 697-703.
63. Patterson K, Kapur SP, Chandra RS (1985). Hepatocellular carcinoma in a non-cirrhotic infant after prolonged parenteral nutrition. J Pediatr 27:734-45.
64. Yuan J-M, Govindarajan S, Arakawa K, Yu MC (2004). Synergism of alcohol, diabetes and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101:1009-17.
65. Naccarato R, Farinati F (1991). Hepatocellular carcinoma, alcohol and cirrhosis: facts and hypothesis. DigDis Sci 36:1137-42.
66. Tsai J-F, Jeng J-E, Chuang L-Y, et al. (2004). Betel quid chewing as a risk factor for HCC. Medicine 83:176-87.
67. Kondo F, Hiroka N, Wada K, Kondo Y (1987). Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch A PatholAnat Histopathol 411:15-21.
68. Kondo F, Wada K, Nagato Y (1989). Biopsy diagnosis of well differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9: 751-5.
69. Sakamoto M, Hirohashi S, Tsuda H, et al. (1988). Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res 15:7294-7.
70. Thiese ND (1995). Macroregenerative (dysplastic) nodules and hepatocarcino-genesis: theoretical and clinical considerations. Semin Liver Dis 15:360-71.
71. Thiese ND (1997). Precursor lesions of hepatocellular carcinoma. In: Tsui WMS, Leong AS-Y, Liew CT, Ng WF (eds.), Pathology of Liver Transplantation, Viral Hepatitis, and Tumors, International Academy of Pathology (Hong Kong Division), Hong Kong, pp. 87-92.
72. Takayama T, Makuuchi M, Hirohashi S, et al. (1990). Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336: 1150-3.
73. Esumi M, Aritaka T, Arii M, et al. (1986). Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res 46:5767-71.
74. Ojanguren I, Castella E, Ariza A, et al. (1997). Liver cell atypias: acomparative study in cirrhosis with and without hepatocellular carcinoma. Histopathology 30:106-12.
75. Leong AS-Y, Robbins P, Spagnolo DV (1995). Tumor genes and their proteins in cytologic and surgical specimens. Relevance and detection systems. Diagn Cytopathol 13:411-22.
76. Farber E, Rubin H (1991). Cellular adaptation in the origin and development of cancer. Cancer Res 51:2751-61.
77. Bressac B, Kew MC, Wands JR, Ozturk M (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-31.
78. Scorsone KA, Zhou YZ, Butel JS, Slagle BL (1992). P53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 52:1635-8.
79. Ushijima T, Morimura K, Hosoya Y (1997). Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hyper-methylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci USA 94:2103-5.
80. Hernandez L, Allen PT, Poirier LA, Lijinski W (1989). S-adenosylmethionine, S-adenosylhomocysteine and DNA methylation levels in the liver of rats fed methapyrilene and analogs. Carcinogenesis 10:557-62.
81. Locker J, Reddy TV, Lombardi B (1986). DNA methylation and hepatocar-cinogenesis in rats fed a choline-devoid diet. Carcinogenesis 7:1309-12.
82. 6-methylguanine in cirrhosis. J Hepatol 25:158-65.
83. Chan JY-H, Lo K-W, Li H-M, Liew CT (1999). Molecular aspects. In: Leong AS-Y, Liew CT, Lau JWY, Johnson PJ (eds.), Hepatocellular Carcinoma. Contemporary Diagnosis, Investigation and Management, Arnold, London, England, pp. 131-45.
84. Farber E (1996). Alcohol and other chemicals in the development of hepatocellular carcinoma. Clin Lab Med 16:377-94.
85. Kim CM, Koike K, Saito I (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-20.
86. Koike K (1995). Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 38:134-42.
87. Korba BE, Wells FV, Baldwin B, et al. (1989). Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 9:461-70.
88. Sherman M (1995). Hepatocellular carcinoma. Gastroenterologist 3:55-6.